Arcadia Biosciences (NASDAQ:RKDA) Stock Price Crosses Above 50-Day Moving Average – Here’s Why

Arcadia Biosciences, Inc. (NASDAQ:RKDAGet Free Report)’s share price passed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $3.78 and traded as high as $3.80. Arcadia Biosciences shares last traded at $3.71, with a volume of 17,323 shares trading hands.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Arcadia Biosciences in a research note on Monday. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company currently has a consensus rating of “Sell”.

View Our Latest Stock Analysis on RKDA

Arcadia Biosciences Stock Down 0.5%

The stock’s 50-day moving average price is $3.78 and its 200 day moving average price is $4.15. The firm has a market capitalization of $5.09 million, a price-to-earnings ratio of 1.46 and a beta of 0.57.

Arcadia Biosciences (NASDAQ:RKDAGet Free Report) last posted its quarterly earnings results on Friday, November 7th. The basic materials company reported $0.62 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.54) by $1.16. The firm had revenue of $1.30 million for the quarter, compared to analyst estimates of $1.90 million. Arcadia Biosciences had a negative net margin of 139.36% and a negative return on equity of 34.75%.

Arcadia Biosciences Company Profile

(Get Free Report)

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.

See Also

Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.